
Overview
BioMaxima S.A. is a Polish, Warsaw Stock Exchange-listed manufacturer of microbiological media, reagents and in vitro diagnostics equipment. The company provides microbiology, molecular diagnostics and cell culture products, laboratory diagnostics and disposable materials. It also runs training courses for laboratories, including validation and verification of microbiological test methods and Legionella diagnostics.
Financials
Revenue history (in m)
Filing timeliness
1 of 6 financial statements was filed late (for 2023, 28 days late). All were audited by a statutory auditor.
- 202517/06/2026
- 202401/07/2025
- 202312/08/2024
- 202229/06/2023
- 202115/06/2022
- 202023/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 8.52
- High
- PLN 8.52
- Low
- PLN 8.40
- Volume
- 2K
- Avg. vol.
- 4.02K
- Market cap
- PLN 35.22M
- P/E ratio
- 44.21
- EPS
- PLN 0.19
- Shares outstanding
- 4.19M
- 52-week
- PLN 8.40 – 9.41
- Dividend yield
- 5.95%
- Dividend
- PLN 0.50
- Ex dividend date
- Jun 16, 2023
- ISIN
- PLBIOMX00015
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 3.75m | USD 207.73k | USD 97.78k |
| Q1 2026 | USD 4.27m | USD 146.14k | USD 88.60k |
| Q4 2025 | USD 4.33m | USD 197.64k | USD 106.23k |
| Q3 2025 | USD 3.51m | USD -5.78k | USD -76.34k |
Results for Q3 2026:Nov 30, 2026
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Microbiological culture media
- Antibiotic discs
- Gradient strips for antimicrobial susceptibility testing
- PCR testing
- Laboratory reagents
- Diagnostic equipment
- Disposable materials
Websites
- biomaxima.comBiomaximaGoogle AnalyticsGoogle Tag ManagerApache
Public procurement
1008 tenders recorded as contractor: 728 national ($8,976,950) and 280 EU ($4,417,330).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 17, 2026 | Successive supply of microbiological culture media, cassette tests and tests for determining MIC for the microbiological diagnostics laboratory | –– | Szpital Powiatowy w Wodzisławiu Śląskim | |
| Nov 17, 2026 | Supply of single-use medical devices, consumables and laboratory materials | $1,432$1,432 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Działdowie | |
| Nov 13, 2026 | Supply of laboratory reagents together with the lease of analyzers | $26,623$26,623 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Bielsku Podlaskim |
The company is the contractor in 561 public sector contracts, worth USD 1.08m in total. They were signed with 192 public buyers. The largest number (4) were signed with Radomski Szpital Specjalistyczny Im. Dr Tytusa Chałubińskiego.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 17, 2026 | Reagents | $37.99 | Uniwersytet Marii Curie-Skłodowskiej | |
| Nov 16, 2026 | Single-use medical devices | $1,432 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Działdowie | |
| Nov 16, 2026 | Ksylose Broth acc. to ISO 11290 / 5ml; Ramnose Broth acc. to ISO 11290 / 5ml; Mueller Hinton 2 LAB-AGAR; Blood agar 2 + 5% krew barania acc. to ISO 11290; Chromogenic Listeria lab agar (ALOA); Palcam agar | $97.78 | Uniwersytet Warszawski |
Biomaxima has been a party to 3 cases before the National Appeal Chamber (since 2020). In 3 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| May 4, 2021 | Clarifications of the tender content | Upheld | Świętokrzyskie Centrum Onkologii | |
| Nov 12, 2020 | Misleading the contracting authority | Dismissed | Instytut "Centrum Zdrowia Matki Polki" | |
| Nov 4, 2020 | Judgment | Upheld | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny |
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| BIOMAXIMA | Z.486137 | 1, 5, 9, 10, 26, 29, 35, 39, 42, 44 | Protected | May 21, 2028 |
| Mark | Protected until | |
|---|---|---|
| BIOMAXIMA | May 21, 2028 |
Job offers
The company lists 4 job openings on its own careers page: biomaxima.com/kariera.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to submit declarations and to sign on behalf of the company.
Supervisory board
Beneficial owners
Biomaxima is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Bank accounts
Registered as a VAT taxpayer on 2002-09-16.
- Bank Gospodarstwa Krajowego74 1130 1206 0028 9181 2120 0001
51 1240 5497 1787 0010 6544 0473
85 1160 2202 0000 0003 4504 3406
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 26, 2011 | Merger plan |
Public aid
44 public aid cases recorded, with a total value of $4,945,134.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $14,675$14,675 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $11,217$11,217 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $9,581$9,581 | Prezes Banku Gospodarstwa Krajowego |
European Funds
20 projects co-financed from European Funds recorded, with total EU co-financing of $5,635,659.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-07-01 | Implementation of Biomaxima's R&D results on new gradient MIC strip tests | $259.8K$259,789 | European Funds for Lubelskie 2021-2027 | |
| 2025-11-02 | Promotion of Biomaxima products through participation in international trade fairs | $70,856$70,856 | European Funds for Lubelskie 2021-2027 | |
| 2025-10-01 | Increasing the competitiveness of Biomaxima by implementing the results of R&D work on new paper antibiotic disks | $275.7K$275,699 | European Funds for Lubelskie 2021-2027 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Radiometer sp. z o.o. | $67,114,263.91 | radiometer.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss Biomed S.A. | $40,633,950.51 | biomed.pl | ||
| Euroimmun Polska sp. z o.o. | $30,318,011.37 | euroimmun.pl | ||
| PZ Cormay S.A. | $17,563,787.04 | pzcormay.pl | ||
| Synthaverse S.A. | $11,561,778.00 | synthaverse.com | ||
| Hydrex Diagnostics sp. z o.o. | $10,828,052.63 | hydrex.pl | ||
| Biomerieux Ssc Europe sp. z o.o. | $7,136,581.79 | biomerieux.com | ||
| Bacto - Tech sp. z o.o. | $2,910,364.95 | bactotech.pl | ||
| BIO-Ksel sp. z o.o. | $2,098,255.87 | bio-ksel.com | ||
| Kleverlab sp. z o.o. | $1,624,706.12 | kleverlab.eu |
Change history
| Date | Event | |
|---|---|---|
| 2023-09-01 | Share capital reduction (4,373,305.00 PLN → 4,193,118.00 PLN) | |
| 2023-04-05 | Share capital increase (4,328,500.00 PLN → 4,373,305.00 PLN) | |
| 2022-03-31 | Share capital increase (4,320,000.00 PLN → 4,328,500.00 PLN) | |
| 2021-02-26 | Share capital increase (4,210,000.00 PLN → 4,320,000.00 PLN) | |
| 2020-04-28 | Share capital increase (3,730,000.00 PLN → 4,210,000.00 PLN) |
FAQ
Last updated: 2026-06-19